BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

324 related articles for article (PubMed ID: 30727888)

  • 1. Regulation of Vaginal Microbiome by Nitric Oxide.
    Yeruva T; Lee CH
    Curr Pharm Biotechnol; 2019; 20(1):17-31. PubMed ID: 30727888
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vaginal microbiome.
    Buchta V
    Ceska Gynekol; 2018; 83(5):371-379. PubMed ID: 30848142
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An exploratory pilot study evaluating the supplementation of standard antibiotic therapy with probiotic lactobacilli in south African women with bacterial vaginosis.
    Marcotte H; Larsson PG; Andersen KK; Zuo F; Mikkelsen LS; Brandsborg E; Gray G; Laher F; Otwombe K
    BMC Infect Dis; 2019 Sep; 19(1):824. PubMed ID: 31533663
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vaginal Microbiota.
    Mendling W
    Adv Exp Med Biol; 2016; 902():83-93. PubMed ID: 27161352
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of biofilms in bacterial vaginosis by an amphoteric tenside pessary-clinical study and microbiota analysis.
    Gottschick C; Deng ZL; Vital M; Masur C; Abels C; Pieper DH; Rohde M; Mendling W; Wagner-Döbler I
    Microbiome; 2017 Sep; 5(1):119. PubMed ID: 28903767
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vaginal microbiota and the potential of Lactobacillus derivatives in maintaining vaginal health.
    Chee WJY; Chew SY; Than LTL
    Microb Cell Fact; 2020 Nov; 19(1):203. PubMed ID: 33160356
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanistic insights into the action of probiotics against bacterial vaginosis and its mediated preterm birth: An overview.
    Basavaprabhu HN; Sonu KS; Prabha R
    Microb Pathog; 2020 Apr; 141():104029. PubMed ID: 32014462
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Contraceptive rings promote vaginal lactobacilli in a high bacterial vaginosis prevalence population: A randomised, open-label longitudinal study in Rwandan women.
    Crucitti T; Hardy L; van de Wijgert J; Agaba S; Buyze J; Kestelyn E; Delvaux T; Mwambarangwe L; De Baetselier I; Jespers V;
    PLoS One; 2018; 13(7):e0201003. PubMed ID: 30036385
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of combined oral contraceptives, depot medroxyprogesterone acetate and the levonorgestrel-releasing intrauterine system on the vaginal microbiome.
    Brooks JP; Edwards DJ; Blithe DL; Fettweis JM; Serrano MG; Sheth NU; Strauss JF; Buck GA; Jefferson KK
    Contraception; 2017 Apr; 95(4):405-413. PubMed ID: 27913230
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bacterial vaginosis: a review on clinical trials with probiotics.
    Mastromarino P; Vitali B; Mosca L
    New Microbiol; 2013 Jul; 36(3):229-38. PubMed ID: 23912864
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of lactic acid production by probiotic Lactobacillus species in vaginal health.
    Tachedjian G; Aldunate M; Bradshaw CS; Cone RA
    Res Microbiol; 2017; 168(9-10):782-792. PubMed ID: 28435139
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lactobacilli-containing vaginal probiotics to cure or prevent bacterial or fungal vaginal dysbiosis: a systematic review and recommendations for future trial designs.
    van de Wijgert J; Verwijs MC
    BJOG; 2020 Jan; 127(2):287-299. PubMed ID: 31299136
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Promising Prebiotic Candidate Established by Evaluation of Lactitol, Lactulose, Raffinose, and Oligofructose for Maintenance of a Lactobacillus-Dominated Vaginal Microbiota.
    Collins SL; McMillan A; Seney S; van der Veer C; Kort R; Sumarah MW; Reid G
    Appl Environ Microbiol; 2018 Mar; 84(5):. PubMed ID: 29269494
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vaginosis: Advances in new therapeutic development and microbiome restoration.
    Mohankumar B; Shandil RK; Narayanan S; Krishnan UM
    Microb Pathog; 2022 Jul; 168():105606. PubMed ID: 35644292
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The urinary microbiota of men and women and its changes in women during bacterial vaginosis and antibiotic treatment.
    Gottschick C; Deng ZL; Vital M; Masur C; Abels C; Pieper DH; Wagner-Döbler I
    Microbiome; 2017 Aug; 5(1):99. PubMed ID: 28807017
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cutting edge: the vaginal microflora and bacterial vaginosis.
    Verstraelen H
    Verh K Acad Geneeskd Belg; 2008; 70(3):147-74. PubMed ID: 18669158
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Connecting the Dots: Translating the Vaginal Microbiome Into a Drug.
    Lagenaur LA; Hemmerling A; Chiu C; Miller S; Lee PP; Cohen CR; Parks TP
    J Infect Dis; 2021 Jun; 223(12 Suppl 2):S296-S306. PubMed ID: 33330916
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of different contraceptive methods on the vaginal microbiome.
    Bastianelli C; Farris M; Bianchi P; Benagiano G
    Expert Rev Clin Pharmacol; 2021 Jul; 14(7):821-836. PubMed ID: 33863265
    [No Abstract]   [Full Text] [Related]  

  • 19. Is the role of human female reproductive tract microbiota underestimated?
    Kamińska D; Gajecka M
    Benef Microbes; 2017 May; 8(3):327-343. PubMed ID: 28504576
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ecological dynamics of the vaginal microbiome in relation to health and disease.
    Greenbaum S; Greenbaum G; Moran-Gilad J; Weintraub AY
    Am J Obstet Gynecol; 2019 Apr; 220(4):324-335. PubMed ID: 30447213
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.